Aiko Maejima

Neoadjuvant crizotinib in ALK-rearranged inflammatory myofibroblastic tumor of the urinary bladder

Yoshiyuki Nagumo, Aiko Maejima, Yuta Toyoshima et al. · International Journal of Surgery Case Reports · 2018 · 33 citations · Full text

Medicine, Oncology, Surgery +17

Interim results of a real-world observational study of eribulin in soft tissue sarcoma including rare subtypes

Eisuke Kobayashi, Yoichi Naito, Naofumi Asano et al. · Japanese Journal of Clinical Oncology · 2019 · 25 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Clinical outcomes of definitive whole pelvic radiotherapy for clinical lymph node metastatic prostate cancer

Keisuke Tsuchida, Koji Inaba, Tairo Kashihara et al. · Cancer Medicine · 2020 · 16 citations · Full text

Medicine, Oncology, Radiation Oncology +17

The clinical significance of perioperative inflammatory index as a prognostic factor for patients with retroperitoneal soft tissue sarcoma

Yoshiyuki Matsui, Ayumu Matsuda, Aiko Maejima et al. · International Journal of Clinical Oncology · 2022 · 16 citations

Medicine, Perioperative Medicine, Surgery +8

Low HER2 expression is a predictor of poor prognosis in stage I triple-negative breast cancer

Tomomi Sanomachi, Hitomi Sumiyoshi Okuma, Rui Kitadai et al. · Frontiers in Oncology · 2023 · 15 citations · Full text

Medicine, Oncology, Breast Oncology +14